ASTAIRE

A Double-Blind, Randomised, Placebo-Controlled, Multicentre, Dose-Escalating Study of AZD1305 Given Intravenously for Conversion to Sinus Rhythm in Patients with Atrial Fibrillation

Stage
klaar
Medicine
AZD1305
Population
Ritme
Phase
II
First Patient In
-
Last Patient In
-
Last Patient Last Visit
-
The page has expired.